Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Details Narrative)

v3.8.0.1
Discontinued Operations (Details Narrative) - USD ($)
12 Months Ended
Sep. 27, 2017
Jul. 19, 2016
Dec. 31, 2017
Dec. 31, 2016
Sep. 29, 2016
Equity ownership percentage     20.00%    
Notes payable      
Indebtedness and other obligations     7,800,000    
Due to related party     7,300,000    
Number of common shares issued upon conversion, value     7,300,000 2,231,829  
Genomas Acquisition [Member]          
Goodwill impairment charge     1,000,000    
Series F Preferred Stock [Member]          
Preferred stock stated value $ 1,750,000   17,500  
Conversion price per share $ 29.25        
Number of common shares issued upon conversion, shares 59,829        
Number of common shares issued upon conversion, value $ 174,097        
Genomas, Inc. [Member]          
Cash   $ 250,000      
Due to related party       400,000  
Genomas, Inc. [Member] | Hartford Healthcare Corporation [Member]          
Equity ownership percentage   15.00%      
Notes payable   $ 1,500,000      
Genomas, Inc. [Member] | Series F Preferred Stock [Member]          
Preferred stock stated value $ 174,097        
Advanced Molecular Services Group [Member] | Genomas Acquisition [Member]          
Goodwill impairment charge     $ 914,972    
Stock Purchase Agreement [Member] | Genomas, Inc. [Member]          
Equity ownership percentage         85.00%
Indebtedness and other obligations       $ 1,000,000  
Stock Purchase Agreement [Member] | Genomas, Inc. [Member] | Series F Preferred Stock [Member]          
Preferred stock shares designated         1,750,000